Research programme: metabolic disorders therapy - Particle Therapeutics

Drug Profile

Research programme: metabolic disorders therapy - Particle Therapeutics

Alternative Names: PRT 001; PRT 003

Latest Information Update: 18 Dec 2015

Price : $50

At a glance

  • Originator Particle Therapeutics
  • Class Pancreatic hormones
  • Mechanism of Action Glucagon receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Hypoglycaemia

Most Recent Events

  • 18 Dec 2015 Discontinued - Preclinical for Hypoglycaemia in United Kingdom (Injection)
  • 30 Aug 2007 Early research in Hypoglycaemia treatment in United Kingdom (Injection, Powder)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top